A patient is prescribed inamrinone (Inocor) by continuous intravenous infusion. When you make rounds and assess the patient, the intravenous bag infusing is labeled (Primacor). What should you do?
a. Stop the infusion and notify the prescriber.
b. Assess the infusion site for a blood return.
c. Document the infusion and site conditions as the only action.
d. Slow the infusion rate because Primacor is more potent than Inocor.
Question 2
What is the most important reason intravenous potassium is considered a high alert drug?
a. When intravenous potassium is administered at too low a dose its mechanism of action is greatly reduced.
b. Intravenous potassium is a highly irritating solution and can cause significant pain or burning at the infusion site.
c. Administering too much intravenous potassium or administering it too quickly may cause life-threatening problems.
d. Excessive blood potassium levels can lead to nausea, vomiting, severe diarrhea, abdominal cramping, and other intestinal problems.
Continuous variation in a polygenic trait.
Patient teaching: neck assessment
Patient teaching: female genetalia and reproductive tract assessment
Positioning the Patient in the Fowler’s Position
Continuous vs. Saltatory Conduction